191 related articles for article (PubMed ID: 27795830)
1. Advance in microRNA as a potential biomarker for early detection of pancreatic cancer.
Huang J; Liu J; Chen-Xiao K; Zhang X; Lee WN; Go VL; Xiao GG
Biomark Res; 2016; 4():20. PubMed ID: 27795830
[TBL] [Abstract][Full Text] [Related]
2. [Pancreatic cancer and microRNAs].
Hwang JH
Korean J Gastroenterol; 2012 Jun; 59(6):395-400. PubMed ID: 22735871
[TBL] [Abstract][Full Text] [Related]
3. microRNA signature for human pancreatic cancer invasion and metastasis.
Cheng H; Shi S; Cai X; Long J; Xu J; Liu C; Yu X
Exp Ther Med; 2012 Aug; 4(2):181-187. PubMed ID: 22970025
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
[TBL] [Abstract][Full Text] [Related]
5. microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer.
Funamizu N; Honjo M; Tamura K; Sakamoto K; Ogawa K; Takada Y
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831572
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
Neelakandan K; Babu P; Nair S
Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs and metastasis: small RNAs play big roles.
Kim J; Yao F; Xiao Z; Sun Y; Ma L
Cancer Metastasis Rev; 2018 Mar; 37(1):5-15. PubMed ID: 29234933
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.
Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X
Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023
[TBL] [Abstract][Full Text] [Related]
10. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
11. microRNA regulation of human pancreatic cancer stem cells.
Xu YF; Hannafon BN; Ding WQ
Stem Cell Investig; 2017; 4():5. PubMed ID: 28217707
[TBL] [Abstract][Full Text] [Related]
12. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
13. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer.
Jiang PC; Bu SR
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):511-516. PubMed ID: 31610988
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
16. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer.
Wang Y; Zhou L; Lu J; Jiang B; Liu C; Guo J; Xiao GG
Cancer Cell Int; 2020; 20():457. PubMed ID: 32973402
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers.
Fedorko M; Pacik D; Wasserbauer R; Juracek J; Varga G; Ghazal M; Nussir MI
Int J Biol Markers; 2016 Feb; 31(1):e26-37. PubMed ID: 26481440
[TBL] [Abstract][Full Text] [Related]
19. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition.
Zhao X; Lu Y; Nie Y; Fan D
Curr Cancer Drug Targets; 2013 Nov; 13(9):935-44. PubMed ID: 24168189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
